SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: schadenfreude who wrote (963)11/20/1997 2:24:00 PM
From: Andrew H  Read Replies (1) of 2173
 
Almost all of Murphy's long term biotech predictions are all wet. A few years ago he was prediction that many of these stocks would already be at 100! Its really a joke.

As for AMLN, it is likely to be dead money or worse for quite a while here. However, I would be a buyer at 4, since there is a reasonable possibility that pramlintide will eventually be approved. By the time it is, there will most likely be a number of treatments available for Type 11, but Type I is still a large market.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News